RG
SYRS
Redmile Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,912
| Closed | -$174K | – | 78 |
|
|
2021
Q3 | $174K | Hold |
38,912
| – | – | ﹤0.01% | 74 |
|
|
2021
Q2 | $212K | Sell |
38,912
-173,379
| -82% | -$945K | ﹤0.01% | 85 |
|
|
2021
Q1 | $1.59M | Hold |
212,291
| – | – | 0.02% | 82 |
|
|
2020
Q4 | $2.3M | Hold |
212,291
| – | – | 0.03% | 83 |
|
|
2020
Q3 | $1.88M | Hold |
212,291
| – | – | 0.03% | 75 |
|
|
2020
Q2 | $2.26M | Hold |
212,291
| – | – | 0.04% | 76 |
|
|
2020
Q1 | $1.26M | Hold |
212,291
| – | – | 0.04% | 63 |
|
|
2019
Q4 | $1.47M | Sell |
212,291
-3,676,461
| -95% | -$25.4M | 0.04% | 61 |
|
|
2019
Q3 | $40.4M | Buy |
3,888,752
+268,376
| +7% | +$2.79M | 1.35% | 22 |
|
|
2019
Q2 | $33.5M | Buy |
3,620,376
+1,975,176
| +120% | +$18.3M | 0.95% | 32 |
|
|
2019
Q1 | $15M | Sell |
1,645,200
-4,338
| -0.3% | -$39.6K | 0.44% | 50 |
|
|
2018
Q4 | $9.19M | Sell |
1,649,538
-6,600
| -0.4% | -$36.8K | 0.37% | 52 |
|
|
2018
Q3 | $19.7M | Buy |
1,656,138
+24,901
| +2% | +$297K | 0.61% | 53 |
|
|
2018
Q2 | $16.7M | Sell |
1,631,237
-21,003
| -1% | -$214K | 0.57% | 47 |
|
|
2018
Q1 | $21.4M | Buy |
1,652,240
+1,015,008
| +159% | +$13.2M | 0.83% | 37 |
|
|
2017
Q4 | $6.2M | Sell |
637,232
-4,187
| -0.7% | -$40.7K | 0.27% | 55 |
|
|
2017
Q3 | $9.44M | Sell |
641,419
-331,841
| -34% | -$4.88M | 0.47% | 46 |
|
|
2017
Q2 | $15.7M | Buy |
973,260
+20,520
| +2% | +$330K | 0.95% | 39 |
|
|
2017
Q1 | $15.2M | Buy |
952,740
+4,300
| +0.5% | +$68.5K | 0.99% | 40 |
|
|
2016
Q4 | $11.5M | Buy |
948,440
+55,658
| +6% | +$677K | 0.99% | 28 |
|
|
2016
Q3 | $11.7M | Sell |
892,782
-53,400
| -6% | -$702K | 0.93% | 29 |
|
|
2016
Q2 | $15.1M | Buy |
+946,182
| New | +$15.1M | 1.44% | 26 |
|